These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24262118)

  • 1. Validation of a modified version of the PRIME screen for psychosis-risk symptoms in a non-clinical Kenyan youth sample.
    Owoso A; Ndetei DM; Mbwayo AW; Mutiso VN; Khasakhala LI; Mamah D
    Compr Psychiatry; 2014 Feb; 55(2):380-7. PubMed ID: 24262118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosis risk screening in youth: a validation study of three self-report measures of attenuated psychosis symptoms.
    Kline E; Wilson C; Ereshefsky S; Denenny D; Thompson E; Pitts SC; Bussell K; Reeves G; Schiffman J
    Schizophr Res; 2012 Oct; 141(1):72-7. PubMed ID: 22921375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for Differential Predictive Performance of the Prime Screen Between Black and White Help-Seeking Youths.
    Millman ZB; Rakhshan Rouhakhtar PJ; DeVylder JE; Smith ME; Phalen PL; Woods SW; Walsh BC; Parham B; Reeves GM; Schiffman J
    Psychiatr Serv; 2019 Oct; 70(10):907-914. PubMed ID: 31310187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying youth at risk for psychosis using the Behavior Assessment System for Children, Second Edition.
    Thompson E; Kline E; Reeves G; Pitts SC; Schiffman J
    Schizophr Res; 2013 Dec; 151(1-3):238-44. PubMed ID: 24119463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A self-reported instrument for prodromal symptoms of psychosis: testing the clinical validity of the PRIME Screen-Revised (PS-R) in a Japanese population.
    Kobayashi H; Nemoto T; Koshikawa H; Osono Y; Yamazawa R; Murakami M; Kashima H; Mizuno M
    Schizophr Res; 2008 Dec; 106(2-3):356-62. PubMed ID: 18809299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosis risk screening with the Prodromal Questionnaire--brief version (PQ-B).
    Loewy RL; Pearson R; Vinogradov S; Bearden CE; Cannon TD
    Schizophr Res; 2011 Jun; 129(1):42-6. PubMed ID: 21511440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Early Psychosis Screener (EPS): Quantitative validation against the SIPS using machine learning.
    Brodey BB; Girgis RR; Favorov OV; Addington J; Perkins DO; Bearden CE; Woods SW; Walker EF; Cornblatt BA; Brucato G; Walsh B; Elkin KA; Brodey IS
    Schizophr Res; 2018 Jul; 197():516-521. PubMed ID: 29358019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of psychosis risk symptoms in Kenya.
    Mamah D; Mbwayo A; Mutiso V; Barch DM; Constantino JN; Nsofor T; Khasakhala L; Ndetei DM
    Compr Psychiatry; 2012 Jul; 53(5):516-24. PubMed ID: 21945193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosis-like experiences and distress among adolescents using mental health services.
    Kline E; Thompson E; Bussell K; Pitts SC; Reeves G; Schiffman J
    Schizophr Res; 2014 Feb; 152(2-3):498-502. PubMed ID: 24411529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and prediction of clinical high risk of psychosis in Chinese outpatients using two-stage screening.
    Xu L; Wang Y; Cui H; Tang Y; Wang J; Tang X; Zhang B; Wei Y; Zhu Y; Jiang L; Qian Z; Li H; Zhang T; Wang J
    Schizophr Res; 2018 Dec; 202():284-290. PubMed ID: 29929774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What's the risk? The frequency of false positives in psychosis risk screening instruments.
    Herrera S; Fietzer AW
    Psychol Serv; 2021 May; 18(2):137-146. PubMed ID: 31192678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric Properties of Prodromal Questionnaire-Brief Version among Chinese Help-Seeking Individuals.
    Xu L; Zhang T; Zheng L; Li H; Tang Y; Luo X; Sheng J; Wang J
    PLoS One; 2016; 11(2):e0148935. PubMed ID: 26859774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The WERCAP Screen and the WERC Stress Screen: psychometrics of self-rated instruments for assessing bipolar and psychotic disorder risk and perceived stress burden.
    Mamah D; Owoso A; Sheffield JM; Bayer C
    Compr Psychiatry; 2014 Oct; 55(7):1757-71. PubMed ID: 25128205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Italian version of the 92-item Prodromal Questionnaire: Concurrent validity with the SIPS and factor analysis in a sample of 258 outpatients aged 11-36years.
    Kotzalidis GD; Solfanelli A; Piacentino D; Savoja V; Fiori Nastro P; Curto M; Lindau JF; Masillo A; Brandizzi M; Fagioli F; Raballo A; Gebhardt E; Preti A; D'Alema M; Fucci MR; Miletto R; Andropoli D; Leccisi D; Girardi P; Loewy RL; Schultze-Lutter F
    Schizophr Res; 2017 Nov; 189():50-56. PubMed ID: 28254200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Item-level endorsement on the Prodromal Questionnaire in a large non-clinical sample.
    Capizzi R; Pierce KM; Olino TM; Ellman LM
    Schizophr Res; 2022 Oct; 248():309-319. PubMed ID: 36155304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The psychometric properties of the Washington Early Recognition Center Affectivity and Psychosis (WERCAP) screen in adults in the Kenyan context: Towards combined large scale community screening for affectivity and psychosis.
    Ndetei D; Pike K; Mutiso V; Tele A; Gitonga I; Rebello T; Musyimi C; Mamah D
    Psychiatry Res; 2019 Dec; 282():112569. PubMed ID: 31727439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for schizophrenia in initial prodromal phase: Detecting the sub-threshold psychosis.
    Razali SM; Abidin ZZ; Othman Z; Yassin MA
    Asian J Psychiatr; 2015 Aug; 16():26-31. PubMed ID: 26182843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-Report Instruments for Clinical Monitoring of Psychosis Risk States.
    Kline E; Thompson E; Demro C; Bussell K; Reeves G; Schiffman J
    Psychiatr Serv; 2016 Apr; 67(4):456-9. PubMed ID: 26567937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodromal psychosis screening in adolescent psychiatry clinics.
    Loewy RL; Therman S; Manninen M; Huttunen MO; Cannon TD
    Early Interv Psychiatry; 2012 Feb; 6(1):69-75. PubMed ID: 21883972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal validation of psychosis risk screening tools.
    Kline E; Thompson E; Demro C; Bussell K; Reeves G; Schiffman J
    Schizophr Res; 2015 Jul; 165(2-3):116-22. PubMed ID: 25975827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.